Provided by Tiger Trade Technology Pte. Ltd.

Amgen

330.11
-11.5300-3.37%
Pre-market: 330.180.0700+0.02%06:32 EST
Volume:2.80M
Turnover:930.84M
Market Cap:177.76B
PE:25.52
High:341.46
Open:337.76
Low:328.21
Close:341.64
52wk High:346.38
52wk Low:260.55
Shares:538.48M
Float Shares:536.99M
Volume Ratio:1.21
T/O Rate:0.52%
Dividend:9.39
Dividend Rate:2.84%
EPS(TTM):12.93
EPS(LYR):7.62
ROE:81.71%
ROA:7.71%
PB:18.48
PE(LYR):43.34

Loading ...

Goldman Sachs Adjusts Price Target on Amgen to $403 From $400, Maintains Buy Rating

MT Newswires Live
·
19 hours ago

Amgen Advances Leukemia Strategy With Completed Blinatumomab Study in Japan

TIPRANKS
·
19 hours ago

Amgen Inc : Truist Securities Raises Target Price to $319 From $318

THOMSON REUTERS
·
Yesterday

Call for Application for 2026 Tsinghua Amgen Scholars Program

prnewswire
·
Yesterday

Amgen Shares Rise After Upgrade From UBS

MT Newswires Live
·
Yesterday

Amgen Buys Dark Blue In $840 Million Bet On New Leukemia Drugs

Benzinga
·
Yesterday

Weight-Loss Drugmakers' Stocks Jump. Structure Therapeutics up 5%; Eli Lilly Rises 4% to Record High; Amgen up 3%; Roche, Novo up Around 2%

Tiger Newspress
·
Jan 07

UBS Upgrades Amgen to Buy From Neutral, Raises Price Target to $380 From $317

MT Newswires Live
·
Jan 07

Amgen Coverage Assumed by UBS at Buy vs Previous Rating of Neutral

Dow Jones
·
Jan 07

Disco Pharmaceuticals: Enters License Agreement to Advance Novel Cancer Surfaceome Targeted Therapies With Amgen

THOMSON REUTERS
·
Jan 07

Disco Pharmaceuticals: Disco Will Be Eligible to Receive up to $618 Mln Total Potential Deal Value Plus Royalties

THOMSON REUTERS
·
Jan 07

UBS Raises Amgen (AMGN.US) Target to $380: Two Pipeline Drugs Expected to Drive Growth Through 2030

Stock News
·
Jan 07

PRESS DIGEST- Financial Times - January 7

Reuters
·
Jan 07

Weight-Loss Drugmakers' Stocks Jump. Arrowhead up over 17%; Structure Therapeutics up over 6%; Novo Nordisk up 5%; Viking, Pfizer, Eli Lilly up Around 2%

Tiger Newspress
·
Jan 06

BRIEF-Amgen Acquires Dark Blue Therapeutics For Up To $840 Million

Reuters
·
Jan 06

Dark Blue Therapeutics Acquired by Amgen for up to $840 Million

THOMSON REUTERS
·
Jan 06

Amgen acquires Dark Blue Therapeutics to boost oncology research

Reuters
·
Jan 06

Amgen Inc - Buys Dark Blue Therapeutics for up to $840 Mln

THOMSON REUTERS
·
Jan 06

Amgen Acquires Dark Blue Therapeutics, Bolstering Oncology Pipeline

THOMSON REUTERS
·
Jan 06

Top Midday Decliners

MT Newswires Live
·
Jan 06